Insider · CIK 0001320982
Tasos Konidaris
cfoofficer
Files at AMRX (Amneal Pharmaceuticals, Inc.). First filing Mar 7, 2025, latest Aug 15, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $5.6M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AMRX: Amneal Pharmaceuticals, Inc.
AMRXOct 9, 2026 · close 19.91
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 82Strong | Amneal Pharmaceuticals, Inc. | $4.7M 499,730 shares | -80% | +35% from low0% from high | |
| 65Notable | Amneal Pharmaceuticals, Inc. | $891k 100,000 shares | -14% | +17% from low-3% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | AMRX Amneal Pharmaceuticals, Inc. | SOpen-market sale Class A Common Stock | -161,365 | $9.22 | $1.5M | 460,517 | Aug 15, 2025 |
| Aug 14, 2025 | AMRX Amneal Pharmaceuticals, Inc. | SOpen-market sale Class A Common Stock | -119,206 | $9.30 | $1.1M | 341,311 | Aug 15, 2025 |
| Aug 15, 2025 | AMRX Amneal Pharmaceuticals, Inc. | SOpen-market sale Class A Common Stock | -219,159 | $9.43 | $2.1M | 122,152 | Aug 15, 2025 |
| Mar 5, 2025 | AMRX Amneal Pharmaceuticals, Inc. | SOpen-market sale Class A Common Stock | -100,000 | $8.91 | $891k | 621,882 | Mar 7, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Class A Common Stock | +45,290 | - | - | 595,309 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | FTax withholding Class A Common Stock | -16,373 | $8.76 | $143k | 578,936 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Class A Common Stock | +57,340 | - | - | 636,276 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | FTax withholding Class A Common Stock | -24,374 | $8.76 | $214k | 611,902 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Class A Common Stock | +181,159 | - | - | 793,061 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | FTax withholding Class A Common Stock | -92,663 | $8.76 | $812k | 700,398 | Mar 5, 2025 |
| Mar 4, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Class A Common Stock | +43,981 | - | - | 744,379 | Mar 5, 2025 |
| Mar 4, 2025 | AMRX Amneal Pharmaceuticals, Inc. | FTax withholding Class A Common Stock | -22,497 | $8.84 | $199k | 721,882 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -45,290 | $0.00 | $0 | 45,290 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -57,340 | $0.00 | $0 | 114,679 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Performance-Based Restricted Stock Unitsderivative | -181,159 | $0.00 | $0 | 0 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | AGrant or award Performance-Based Restricted Stock Unitsderivative | +228,310 | $0.00 | $0 | 228,310 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +114,155 | $0.00 | $0 | 114,154 | Mar 5, 2025 |
| Mar 4, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -43,981 | $0.00 | $0 | 131,945 | Mar 5, 2025 |
| Mar 1, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Class A Common Stock | +36,197 | - | - | 563,513 | Mar 4, 2025 |
| Mar 1, 2025 | AMRX Amneal Pharmaceuticals, Inc. | FTax withholding Class A Common Stock | -13,494 | $8.67 | $117k | 550,019 | Mar 4, 2025 |
| Mar 1, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -36,197 | $0.00 | $0 | 0 | Mar 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.